We are live on ! Find out more
QTTB icon

Q32 Bio

53 hedge funds and large institutions have $419M invested in Q32 Bio in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

26% more funds holding

Funds holding: 4253 (+11)

25% more capital invested

Capital invested by funds: $336M → $419M (+$82.8M)

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

31.59% less ownership

Funds ownership: 34.65%3.06% (-32%)

Holders
53
Holders Change
+11
Holders Change %
+26.19%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
26
Increased
12
Reduced
10
Closed
15
Calls
Puts
Net Calls
Net Calls Change

QTTB Hedge Fund Activity: Q2 2018 in Review

53 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2018, worth a combined $419M — up 25% from $336M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new QTTB positions and 15 closed out — a net gain of 11 holders — while 12 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $10.6M. The largest seller was Rock Springs Capital Management, cutting an estimated $2.09M.

  • 53 institutional investors held Q32 Bio (QTTB) as of Q2 2018, up from 42 in Q1 2018.
  • Funds reported $419M of Q32 Bio stock for Q2 2018, up 25% quarter-over-quarter.
  • 26 funds opened new Q32 Bio positions in Q2 2018 and 15 closed out, a net change of +11 holders.
  • The largest Q32 Bio buyer in Q2 2018 was BlackRock, an estimated $10.6M added.
  • The largest Q32 Bio seller in Q2 2018 was Rock Springs Capital Management, an estimated $2.09M sold.

Based on aggregated 13F filings for Q2 2018.